A health-economic evaluation of aspirin: primary prevention and cardiovascular disease.
Sakai
Takaaki
T
Saku
Keijiro
K
D001241:Aspirin / Q000191:economics* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000191:economics* / Q000517:prevention & control*; D006293:Health Promotion / Q000191:economics / Q000592:standards; D006801:Humans; D017410:Practice Guidelines as Topic / Q000592:standards; D011322:Primary Prevention / Q000191:economics* / Q000592:standards; D016032:Randomized Controlled Trials as Topic / Q000191:economics
D001241:Aspirin